NO20050088L - Cationically substituted diphenylazofidinones, processes for their preparation, medicaments containing said compounds, and use thereof - Google Patents
Cationically substituted diphenylazofidinones, processes for their preparation, medicaments containing said compounds, and use thereofInfo
- Publication number
- NO20050088L NO20050088L NO20050088A NO20050088A NO20050088L NO 20050088 L NO20050088 L NO 20050088L NO 20050088 A NO20050088 A NO 20050088A NO 20050088 A NO20050088 A NO 20050088A NO 20050088 L NO20050088 L NO 20050088L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- diphenylazofidinones
- processes
- preparation
- medicaments containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Abstract
The invention relates to compounds of formula (I), in which R1, R2, R3, R4, R5 and R6 are defined as cited, in addition to their physiologically compatible salts. The compounds are suitable for use e.g. as hypolipidaemics.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10227507A DE10227507A1 (en) | 2002-06-19 | 2002-06-19 | Cationically substituted diphenylazetidinones, processes for their preparation, medicaments containing these compounds and their use |
PCT/EP2003/005814 WO2004000803A1 (en) | 2002-06-19 | 2003-06-04 | Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050088L true NO20050088L (en) | 2005-01-06 |
Family
ID=29719282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050088A NO20050088L (en) | 2002-06-19 | 2005-01-06 | Cationically substituted diphenylazofidinones, processes for their preparation, medicaments containing said compounds, and use thereof |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1517890B1 (en) |
JP (1) | JP2005533071A (en) |
KR (1) | KR20050010061A (en) |
CN (1) | CN1662494A (en) |
AT (1) | ATE401304T1 (en) |
AU (1) | AU2003238209B2 (en) |
BR (1) | BR0311984A (en) |
CA (1) | CA2490108A1 (en) |
DE (2) | DE10227507A1 (en) |
DK (1) | DK1517890T3 (en) |
ES (1) | ES2310662T3 (en) |
HR (1) | HRP20041202A2 (en) |
IL (1) | IL165790A (en) |
MA (1) | MA27251A1 (en) |
MX (1) | MXPA04012308A (en) |
NO (1) | NO20050088L (en) |
PA (1) | PA8575601A1 (en) |
PL (1) | PL372660A1 (en) |
PT (1) | PT1517890E (en) |
RS (1) | RS108604A (en) |
RU (1) | RU2315753C2 (en) |
SV (1) | SV2004001555A (en) |
TW (1) | TW200406380A (en) |
UY (1) | UY27852A1 (en) |
WO (1) | WO2004000803A1 (en) |
ZA (1) | ZA200409379B (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0215579D0 (en) | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
US7871998B2 (en) | 2003-12-23 | 2011-01-18 | Astrazeneca Ab | Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity |
NZ555320A (en) | 2004-12-03 | 2010-11-26 | Schering Corp | Substituted piperazines as CB1 antagonists |
MX2007012253A (en) * | 2005-04-04 | 2007-12-07 | Univ Pontificia Catolica Chile | The use of ezetimibe in the prevention and treatment of cholesterol gallstones. |
ATE450526T1 (en) | 2005-06-20 | 2009-12-15 | Schering Corp | PIPERIDINE DERIVATIVES SUITABLE AS ANTAGONISTS OF HISTAMINE H3 |
SA06270191B1 (en) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | Novel 2-Azetidinone Derivatives as Cholesterol Absorption Inhibitors for the Treatment of Hyperlipidaemic Conditions |
TW200811098A (en) | 2006-04-27 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
CA2666193A1 (en) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use |
DE102007002260A1 (en) | 2007-01-16 | 2008-07-31 | Sanofi-Aventis | Use of substituted pyranonic acid derivatives for the preparation of medicaments for the treatment of the metabolic syndrome |
EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
DE102007054497B3 (en) | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | New crystalline hydrate form of dodecanedioic acid 4-((2S,3R)-3-((S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl)-2-(4-methoxy-phenyl)-4-oxo-azetidin-1-yl)-benzylamide ((2S,3R,4R,5R)-pentahydroxy-hexyl)-amide useful e.g. to treat hyperlipidemia |
EP2310372B1 (en) | 2008-07-09 | 2012-05-23 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
US9212175B2 (en) | 2009-03-06 | 2015-12-15 | Lipideon Biotechnology Ag | Pharmaceutical hypocholesterolemic compositions |
CN101993403B (en) | 2009-08-11 | 2012-07-11 | 浙江海正药业股份有限公司 | Azetidinone compound and medical applications thereof |
DK2470552T3 (en) | 2009-08-26 | 2014-02-17 | Sanofi Sa | NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
WO2012120055A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683700B1 (en) | 2011-03-08 | 2015-02-18 | Sanofi | Tetra-substituted oxathiazine derivatives, method for their preparation, their usage as medicament and medicament containing same and its use |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
WO2012120053A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10042447A1 (en) * | 2000-08-29 | 2002-03-28 | Aventis Pharma Gmbh | Vertebrate intestinal protein that absorbs cholesterol and use of this protein to identify inhibitors of intestinal cholesterol transport |
DE50110906D1 (en) * | 2000-12-21 | 2006-10-12 | Sanofi Aventis Deutschland | DIPHENYLAZETIDINONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THE MEDICAMENT CONTAINING THESE COMPOUNDS AND THEIR USE |
JP4605990B2 (en) * | 2000-12-21 | 2011-01-05 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Novel 1,2-diphenylazetidinone, process for its preparation, medicament containing the compound, and use thereof for treating lipid metabolism disorders |
IL156552A0 (en) * | 2000-12-21 | 2004-01-04 | Aventis Pharma Gmbh | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
-
2002
- 2002-06-19 DE DE10227507A patent/DE10227507A1/en not_active Withdrawn
-
2003
- 2003-06-04 MX MXPA04012308A patent/MXPA04012308A/en active IP Right Grant
- 2003-06-04 CN CN038140934A patent/CN1662494A/en active Pending
- 2003-06-04 RU RU2005101088/04A patent/RU2315753C2/en not_active IP Right Cessation
- 2003-06-04 AT AT03735534T patent/ATE401304T1/en not_active IP Right Cessation
- 2003-06-04 WO PCT/EP2003/005814 patent/WO2004000803A1/en active IP Right Grant
- 2003-06-04 ES ES03735534T patent/ES2310662T3/en not_active Expired - Lifetime
- 2003-06-04 EP EP03735534A patent/EP1517890B1/en not_active Expired - Lifetime
- 2003-06-04 RS YUP-1086/04A patent/RS108604A/en unknown
- 2003-06-04 CA CA002490108A patent/CA2490108A1/en not_active Abandoned
- 2003-06-04 PL PL03372660A patent/PL372660A1/en not_active Application Discontinuation
- 2003-06-04 KR KR10-2004-7020518A patent/KR20050010061A/en not_active Application Discontinuation
- 2003-06-04 AU AU2003238209A patent/AU2003238209B2/en not_active Ceased
- 2003-06-04 BR BR0311984-0A patent/BR0311984A/en not_active IP Right Cessation
- 2003-06-04 DE DE50310161T patent/DE50310161D1/en not_active Expired - Lifetime
- 2003-06-04 DK DK03735534T patent/DK1517890T3/en active
- 2003-06-04 JP JP2004514659A patent/JP2005533071A/en not_active Abandoned
- 2003-06-04 PT PT03735534T patent/PT1517890E/en unknown
- 2003-06-13 PA PA20038575601A patent/PA8575601A1/en unknown
- 2003-06-16 SV SV2003001555A patent/SV2004001555A/en unknown
- 2003-06-16 UY UY27852A patent/UY27852A1/en unknown
- 2003-06-17 TW TW092116320A patent/TW200406380A/en unknown
-
2004
- 2004-11-22 ZA ZA200409379A patent/ZA200409379B/en unknown
- 2004-12-08 MA MA27989A patent/MA27251A1/en unknown
- 2004-12-15 IL IL165790A patent/IL165790A/en not_active IP Right Cessation
- 2004-12-17 HR HR20041202A patent/HRP20041202A2/en not_active Application Discontinuation
-
2005
- 2005-01-06 NO NO20050088A patent/NO20050088L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2310662T3 (en) | 2009-01-16 |
HRP20041202A2 (en) | 2005-06-30 |
DE50310161D1 (en) | 2008-08-28 |
WO2004000803A1 (en) | 2003-12-31 |
AU2003238209A1 (en) | 2004-01-06 |
RS108604A (en) | 2007-02-05 |
JP2005533071A (en) | 2005-11-04 |
ATE401304T1 (en) | 2008-08-15 |
CA2490108A1 (en) | 2003-12-31 |
DK1517890T3 (en) | 2008-11-10 |
AU2003238209B2 (en) | 2009-01-22 |
RU2315753C2 (en) | 2008-01-27 |
EP1517890B1 (en) | 2008-07-16 |
IL165790A (en) | 2010-04-15 |
IL165790A0 (en) | 2006-01-15 |
EP1517890A1 (en) | 2005-03-30 |
RU2005101088A (en) | 2005-06-27 |
UY27852A1 (en) | 2003-12-31 |
BR0311984A (en) | 2005-04-26 |
MA27251A1 (en) | 2005-03-01 |
CN1662494A (en) | 2005-08-31 |
TW200406380A (en) | 2004-05-01 |
DE10227507A1 (en) | 2004-01-08 |
ZA200409379B (en) | 2006-05-31 |
PL372660A1 (en) | 2005-07-25 |
SV2004001555A (en) | 2004-03-19 |
KR20050010061A (en) | 2005-01-26 |
MXPA04012308A (en) | 2005-02-25 |
PA8575601A1 (en) | 2004-02-07 |
PT1517890E (en) | 2008-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050088L (en) | Cationically substituted diphenylazofidinones, processes for their preparation, medicaments containing said compounds, and use thereof | |
NO20070224L (en) | 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof | |
SE0301700D0 (en) | Novel compounds | |
SE0202133D0 (en) | Novel compounds | |
SE0200920D0 (en) | Novel compounds | |
SE0104140D0 (en) | Novel Compounds | |
NO20054905L (en) | 2-acylamino-4-phenylthiazole derivatives, methods for their preparation and use of the same as in therapeutics | |
NO20062020L (en) | 1-Amino-2-Oxy-Substituted Tetrahydronaphthalene Derivatives, Methods of Preparation thereof, and Their Use as Antiflogistics | |
ATE433447T1 (en) | PYRIMIIDINE COMPOUNDS | |
NO20071642L (en) | N-Benzenesulfonyl-substituted anilino-pyrimidine analogs | |
IS7965A (en) | Thienopyrimidinedione and their use in the development of self-hypersensitivity disease | |
NO20062677L (en) | Benzyl etheramine compounds useful as CCR-5 antagonists | |
SE0102438D0 (en) | New compounds | |
SE0401762D0 (en) | Novel compounds | |
WO2006100081A3 (en) | Substituted oxindole derivatives, medicaments containing the latter and use thereof | |
NO20062021L (en) | Redirected pentanols, their methods of preparation, and their use as antiflogistics | |
EA200801011A1 (en) | DERIVATIVES OF PYRAZINE AS MODULATORS OF SODIUM CHANNELS FOR THE TREATMENT OF PAIN | |
TNSN04250A1 (en) | Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof. | |
NO20054787L (en) | Indene derivatives as pharmaceuticals | |
MY135850A (en) | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use | |
NO20076145L (en) | Ureadeviates, processes for their preparation and use thereof | |
SE0302139D0 (en) | Novel compounds | |
NO20062900L (en) | New connections | |
SE0303541D0 (en) | New compounds | |
NO20043016L (en) | 6-aminomorphinan derivatives, process for preparation and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |